Filing Details
- Accession Number:
- 0001127602-24-021044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-26 16:52:20
- Reporting Period:
- 2024-07-24
- Accepted Time:
- 2024-07-26 16:52:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1835597 | Pepgen Inc. | PEPG | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1923040 | L Michelle Mellion | 321 Harrison Ave., 8Th Floor C/O Pepgen Inc. Boston MA 02118 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-07-24 | 201 | $10.21 | 201 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-07-24 | 201 | $18.01 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-07-25 | 7,571 | $10.21 | 7,571 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-07-25 | 7,571 | $18.06 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-07-24 | 201 | $0.00 | 201 | $10.21 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-07-25 | 7,571 | $0.00 | 7,571 | $10.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 57,571 | 2032-06-30 | No | 4 | M | Direct | |
| 50,000 | 2032-06-30 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date.
Billionaire Hedge Funds
